Islet Biology: From Gene to Cell to Micro-Organ
joint with Diabetes: Glucose Control and Beyond
Organizer(s): Patrick MacDonald, Wen-hong Li, Anna Gloyn and Anette-Gabriele Ziegler Date: January 27 - 31, 2020
Location: Santa Fe Community Convention Center, Santa Fe, NM, USA
For important information on the coronavirus, please click here
Recent years have seen great strides in understanding pancreatic endocrine islet cells. Spurred by new and emerging technologies, we are making discoveries about the impact of genetic variation on islet cells; how islet cell subpopulations differ; communication between islet cells and with the local environment, including components of the immune system; and how these interact to effect islet loss and dysfunction. A more integrated understanding of these processes will lead to important insights into diabetes and its treatment. Connecting researchers in the complimentary fields of genomics, immunology, islet cell function, and single-cell biology will be crucial to realizing this. One of the goals of this Keystone conference is to promote greater integration in our approaches to studying islet biology - spanning from genes, to single cells, to islets as micro-organs, and to the interaction of these with their local environment. Conference participants will learn about new methods and technological approaches among islet-biology investigators. This conference will also help to facilitate the development of new collaborations among attendees. We anticipate that this conference will highlight the challenges and potential new solutions in bringing integrated approaches to islet biology for the advancement of diabetes-related knowledge.
Scholarship Deadline: October 2 2019
Discounted Abstract Deadline: October 2 2019
Abstract Deadline: October 30 2019
Discounted Registration Deadline: December 3 2019
Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email email@example.com if you are interested.
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 1R13DK122818-01
Funding for this conference was made possible (in part) by 1R13DK122818-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.